677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis. - Wikidata - awgldk - TriplyDB

677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.

677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.

http://www.wikidata.org/entity/Q46885439

about

Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.Leveraging human genetics to develop future therapeutic strategies in rheumatoid arthritis RADB: a database of rheumatoid arthritis-related polymorphisms.Old drugs, old problems: where do we stand in prediction of rheumatoid arthritis responsiveness to methotrexate and other synthetic DMARDs?The Frequency of A1298C and C677T Polymorphisms of the Methylentetrahydrofolate Gene in Turkish Patients with Rheumatoid Arthritis: Relationship with Methotrexate Toxicity.Chemotherapy-induced toxicity is highly heritable in Drosophila melanogaster Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate Higher serum folate levels are associated with a lower risk of atopy and wheeze.Pharmacogenetic relevance of MTHFR polymorphisms.Genetic polymorphisms of enzyme proteins and transporters related to methotrexate response and pharmacokinetics in a Japanese population.Polymorphisms and Pharmacogenomics for the Clinical Efficacy of Methotrexate in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis.Effect of genetic polymorphisms in the folate pathway on methotrexate therapy in rheumatic diseases.Genetic risk factors for drug-induced liver injury in rheumatoid arthritis patients using low-dose methotrexate.Methotrexate pharmacogenetics in rheumatoid arthritis: a status report.Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Pharmacogenetics: can genes determine treatment efficacy and safety in JIA?The effect of gene polymorphisms on patient responses to rheumatoid arthritis therapy.Genetic Determinants of Methotrexate Toxicity in Tunisian Patients with Rheumatoid Arthritis: A Study of Polymorphisms Involved in the MTX Metabolic Pathway.Are gene polymorphisms related to treatment outcomes of methotrexate in patients with rheumatoid arthritis? A systematic review and meta-analysis.Lack of association between MTHFR A1298C polymorphism and outcome of methotrexate treatment in rheumatoid arthritis patients: evidence from a systematic review and meta-analysis.Understanding Personalized Medicine in Rheumatoid Arthritis: A Clinician's Guide to the Future.Metaanalysis of methylenetetrahydrofolate reductase (MTHFR) polymorphisms affecting methotrexate toxicity.Current concepts in the genetic diagnostics of rheumatoid arthritis.MTHFR gene polymorphisms and outcome of methotrexate treatment in patients with rheumatoid arthritis: analysis of key polymorphisms and meta-analysis of C677T and A1298C polymorphisms.SLC19A1 80G allele as a biomarker of methotrexate-related gastrointestinal toxicity in Portuguese rheumatoid arthritis patients.Association of MTHFR C677T and A1298C gene polymorphisms with methotrexate efficiency and toxicity in Algerian rheumatoid arthritis patients.The C677T polymorphism in theMTHFRgene is associated with the toxicity of methotrexate in a Spanish rheumatoid arthritis population

P2860

Q33747444-620DA314-192B-4D03-AA9E-141B4FBF9116 Q33888733-D6EE4318-CFE3-4C22-B958-9289A8095C83 Q34185466-A79E5B4C-A9C9-467D-B598-34FDEBEB9B32 Q34559803-0807C7AC-2F9F-447F-8BE4-2E0187CFB6A5 Q35480214-FDA8DEBC-CC79-4D7A-9265-FD61689AE908 Q35830711-91F20587-FFF0-4ED4-90AF-9723E3A4FFEB Q37190006-C673F6E6-EA1B-4329-80FB-AA27D4FDA417 Q37219954-0D873E56-92C7-4196-AE01-6558A3A97D19 Q37264528-53C7F0B4-E5AF-47D7-A428-F673E625577C Q37491021-05952081-688B-4359-87F7-7116A0038EE6 Q37683906-61BE37D7-1F43-40D9-8A6B-6445E125922C Q37946958-A53533F8-7E27-4C2B-9678-522A894CA4CE Q38068540-739848C9-FDD5-4D8F-9333-C6548C5884E5 Q38080147-DDE2A27F-8757-48B2-8B6A-70892588EF8C Q38084444-8BAFF2AE-1109-4DA7-AE88-8E431282533E Q38238947-E3F3A82D-F1A1-4ABC-9A49-CDED85A33043 Q38648460-382584E4-6B71-42F4-AC4F-74AB2BD4285D Q38936379-04A83BCE-47F9-4B69-AEDB-F27320DFD904 Q39043220-12A5B917-6FE4-4F3E-8C3C-2E87D5805015 Q39330126-9F369B99-0EF3-4D61-8186-FD241EC00851 Q39991278-683296ED-5903-4D37-A058-9D145982F52A Q41808826-47ECC7BF-A111-4C79-924F-7035783FE0D1 Q42970803-44303DC8-B88D-407F-9BD0-BCC03BC42606 Q44539907-7862F418-CDD4-4EE8-BD4E-7D0D75573CEB Q45055039-6B8A8B62-7EEB-4CE9-835F-A8A43C6B9A57 Q47134001-516F8D35-DD9D-4056-81C5-D27D2D260FC7 Q58912366-62BF91C7-D786-49FD-B60E-4EDAC4964454

P2860

677C>T and 1298A>C MTHFR polymorphisms affect methotrexate treatment outcome in rheumatoid arthritis.

http://www.wikidata.org/entity/Q46885439

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh-hant

name

677C>T and 1298A>C MTHFR polym ...... tcome in rheumatoid arthritis.

@en

677C>T and 1298A>C MTHFR polym ...... tcome in rheumatoid arthritis.

@nl

type

label

677C>T and 1298A>C MTHFR polym ...... tcome in rheumatoid arthritis.

@en

677C>T and 1298A>C MTHFR polym ...... tcome in rheumatoid arthritis.

@nl

prefLabel

677C>T and 1298A>C MTHFR polym ...... tcome in rheumatoid arthritis.

@en

677C>T and 1298A>C MTHFR polym ...... tcome in rheumatoid arthritis.

@nl

P1433

Q46885439-5D14E742-62C9-4CC6-86BB-91D110C4EFB9

P1476

Q46885439-6986C95A-A54C-4534-A893-10700BBB2569

P2093

Q46885439-1103D107-FECD-4D19-8ECC-3FE381485D61

Q46885439-B76725F7-BB52-4189-9A73-9FFD6012109C

P2860

Q46885439-28DB1B75-A51A-46A7-BD29-09CCBB51EC55

Q46885439-2A795C6B-4602-41DF-8AD4-3072460441C8

Q46885439-32D2253E-BA51-490D-9875-03E00DD590BD

Q46885439-4D4DBBC4-423C-48BD-A264-2A6EFC595A0B

Q46885439-54F5AA0C-D852-4B42-BE97-FF9FF288E96D

Q46885439-5A03D92E-E171-43BB-870D-E933BC73E156

Q46885439-5BCE3A0B-CB80-4FF7-ADD3-2A6CA1B04228

Q46885439-662EAD11-5AD2-448C-AE27-0163F4CB4100

Q46885439-9EB6F24C-DE3A-4813-93B8-70E4BAE677E9

Q46885439-A6C17739-5BF7-4A97-9FCB-AB7BF9228D9A

P304

Q46885439-BD95FDD2-ADEE-413C-B309-8B79650FA4FF

P31

Q46885439-D9F05E12-93C4-4628-BF14-F7087D32D792

P356

Q46885439-6F4233B5-39BF-4A63-BE6F-4965DF068BDC

P433

Q46885439-85497244-F1B1-4B55-B710-3CC11B2B8F99

P478

Q46885439-D98FABE7-1024-4BA0-87DD-5E43906437D2

P50

Q46885439-3D70F3F6-AA91-4554-9111-AE61A5D8C4F0

Q46885439-941DD440-F760-439B-BA2D-979449A68F44

Q46885439-D2E61332-6175-4F31-BF8C-0863BC1D39DE

P577

Q46885439-17F6B211-0F13-4521-9442-7B838878695D

P5875

Q46885439-2CCD4BF3-5EDC-4D79-8A87-EF0DA6244105

P698

Q46885439-77C68516-2698-4616-BD84-998950A9E6A4

P356

14622416.8.11.1551

P1433

Pharmacogenomics

P1476

677C>T and 1298A>C MTHFR polym ...... tcome in rheumatoid arthritis.

@en

P2093

Magdalena Herczynska

http://www.w3.org/2001/XMLSchema#string

Mateusz Kurzawski

http://www.w3.org/2001/XMLSchema#string

P2860

A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase

The folate cycle and disease in humans

Factors associated with toxicity, final dose, and efficacy of methotrexate in patients with rheumatoid arthritis.

Methotrexate related adverse effects in patients with rheumatoid arthritis are associated with the A1298C polymorphism of the MTHFR gene

Racial or ethnic differences in allele frequencies of single-nucleotide polymorphisms in the methylenetetrahydrofolate reductase gene and their influence on response to methotrexate in rheumatoid arthritis.

Efficacy and toxicity of methotrexate in early rheumatoid arthritis are associated with single-nucleotide polymorphisms in genes coding for folate pathway enzymes.

The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on Outcome Measures in Rheumatoid Arthritis Clinical Trials.

Molecular genetics of methylenetetrahydrofolate reductase deficiency.

Effect of folic or folinic acid supplementation on the toxicity and efficacy of methotrexate in rheumatoid arthritis: a forty-eight week, multicenter, randomized, double-blind, placebo-controlled study.

The C677T mutation in the methylenetetrahydrofolate reductase gene: a genetic risk factor for methotrexate-related elevation of liver enzymes in rheumatoid arthritis patients.

P304

1551-1559

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2217/14622416.8.11.1551

http://www.w3.org/2001/XMLSchema#string

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

Krzysztof Safranow

P577

2007-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5812290

http://www.w3.org/2001/XMLSchema#string

P698

18034620

http://www.w3.org/2001/XMLSchema#string